Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
New bond financing agreement in a minimum amount of €3 million in anticipation…
Disclaimer: SAFE SA (the “Company”) has arranged financing in the form of convertible bonds into new or existing shares (OCEANE) with Global Corporate Finance Opportunities 20 (“GCFO 20”), which, after receiving the shares resulting from the conversion of these bonds, is not intended to remain a shareholder of the Company.The shares resulting from the conversion of these bonds will generally be sold on the market at very short notice, which may create strong downward pressure on the...
Nasdaq GlobeNewswire
09/09/2024
Trampoline Market to Reach $1.5 billion, Globally, by 2035 at 4.6% CAGR: Allied…
Prime determinants of growth Prime determinants of growth The trampoline market is expanding due to several important factors. The growing popularity of trampolines as an enjoyable form of physical exercise is a result of people's increased awareness of health and fitness, especially among children and adolescents. The popularity of trampoline parks along with the growth in sports and leisure activities has further stimulated market expansion. Trampolines have also become more...
PR Newswire
09/09/2024
Diamyd Medical to pursue accelerated approval pathway for Type 1 Diabetes…
Diamyd Medical recently announced Fast track designation in the U.S. for Diamyd®, and that the U.S. Food and Drug Administration (FDA) has acknowledged that accelerated approval could be sought based on a demonstration of significant treatment-related benefits on C-peptide levels, a measure of endogenous insulin production, in response to Diamyd® administration. The FDA's Accelerated approval program allows drugs for serious conditions that fills an unmet medical need to be approved based on a…
PR Newswire
09/09/2024
A. Menarini Diagnostics and Nucleix announce a strategic partnership for a…
This non-invasive CE-marked test detects primary or recurrent bladder cancer and upper tract urinary cancer. Bladder EpiCheck is included in the European Association of Urology (EAU) Clinical Guidelines as a urine test that might be used in the initial diagnostic workup of bladder cancer to avoid / implement cystoscopy and in follow-up to monitor for non-muscle invasive bladder cancer (NMIBC) tumor recurrence to replace or postpone cystoscopy. The test is also included in the EAU Clinical…
PR Newswire
09/09/2024
New insights highlight unmet needs for people living with Lennox-Gastaut…
These findings underline the need for new treatments that can target both drug-resistant seizures and the non-seizure symptoms of LGS. These findings underline the need for new treatments that can target both drug-resistant seizures and the non-seizure symptoms of LGS. DrKonrad Werhahn, Global Medical Affairs, UCB, said: "The impact of LGS goes beyond seizures and can include severe cognitive impairment, communication difficulties, psychiatric symptoms, behavioral challenges, and…
PR Newswire
09/09/2024
PolTREG Treg cell therapy for patients with type-1 diabetes shows long-term…
PTG-007 cell therapy resulted in clinical remission in some patients for up to 12 yearsA proportion of patients remained insulin-independent for up to 24 monthsPTG-007 ready to enter pivotal studyData presented at INNODIA EASD conferenceGdańsk, Poland – 9 September 2024– PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases, today announces data showing that treatment with its...
Nasdaq GlobeNewswire
09/09/2024
Roche advances AI-driven cancer diagnostics by expanding its digital pathology…
"We are excited to welcome these new collaborators into our digital pathology ecosystem," said Jill German, Head of Pathology Lab for Roche Diagnostics. "By combining our leadership in tissue diagnostics with a broad offering of state-of-the-art AI technology, we aim to revolutionise cancer research, diagnostics and treatment, ultimately helping clinicians improve the lives of patients worldwide." "We are excited to welcome these new collaborators into our digital…
PR Newswire
09/09/2024
Toshiba Unveils the High-End Masterstroke Series at IFA 2024, Showcasing a New…
As part of Toshiba's newest brand positioning, the Masterstroke Series redefines the role of home appliances in modern living. Moving beyond the mechanical and functional aspects, this series infuses a sense of humanity and high-end design, transforming everyday household items into artistic masterpieces. Embracing the philosophy of "LIFE AS THE BRUSH, HOME AS THE CANVAS," the series envisions living spaces as works of art, where each appliance enhances the aesthetic environment. As…
PR Newswire
09/09/2024
Ultimovacs Announces Updated Data Analysis on UV1 Phase II NIPU Trial in…
Oslo, September 9, 2024:Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces the presentation of updated data analysis from the UV1 Phase II NIPU trial (NCT04300244), at the 2024 ESMO Congress.The NIPU trial evaluated the addition of UV1 telomerase vaccine to immunotherapy with ipilimumab and nivolumab compared with ipilimumab and nivolumab alone, as a second-line treatment for patients...
Nasdaq GlobeNewswire
09/09/2024
Avacta to present updated clinical data on AVA6000 at the European Society for…
8 September 2024 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) CongressAvacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics, today announces that the company will present updated data from the Phase 1a trial of AVA6000 at the 2024 European Society for Medical Oncology (ESMO) Congress,...
Nasdaq GlobeNewswire
09/09/2024
Lyophilized Reagent Beads Market Size to Grow USD 380 Million by 2030 at a CAGR…
Claim Your Free Sample Now: https://reports.valuates.com/request/sample/QYRE-Auto-28Z16292/Global_Lyophilized_Reagent_Beads_Market_Research_Report_2024 Claim Your Free Sample Now: https://reports.valuates.com/request/sample/QYRE-Auto-28Z16292/Global_Lyophilized_Reagent_Beads_Market_Research_Report_2024 Major Factors Driving the Growth of Lyophilized Reagent Beads Market: The market for lyophilized reagent beads is expanding as a result of the growing use of molecular diagnostics,...
PR Newswire
07/09/2024
Friendly Innovations for Homes: Midea Showcases Next-Generation Smart Appliances…
Taking center stage is ECOMASTER, Midea's AI-enabled energy management solution for a wide range of appliances. Combining cloud-connectivity, real-world information, and advanced analytics, ECOMASTER reduces home appliance energy consumption by an average of 30%, without impacting performance. ECOMASTER is available across multiple categories, from air treatment to major appliances. Taking center stage is ECOMASTER, Midea's AI-enabled energy management solution for a wide range of appliances...
PR Newswire
07/09/2024
Changhong's Innovative Technologies Take Center Stage at IFA 2024, Marking New…
On the event's first day, Changhong unveiled its first Canghai Intelligent Agent AI TV, and the industry-leading Changhong AI Large Model specifically engineered for white goods. On the event's first day, Changhong unveiled its first Canghai Intelligent AgentAI TV, and the industry-leading Changhong AI Large Model specifically engineered for white goods. The new AI TV can engage in voice conversations with users, think independently, and adapt through continuous learning. Utilizing its...
PR Newswire
07/09/2024
Fagron's share buy-back program: Weekly update
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 6 September 2024 – 6PM CET Fagron's share buy-back program: Weekly update In the period from 2 September 2024 through 6 September 2024, Fagron purchased 33,500 of its owns shares at an average price of € 19.17 per share corresponding to a total amount of€ 642,302.02. These purchases are part of the share buy-back program of up to 150,000 Fagron shares to fulfill Fagron's obligations under its long-term incentive...
Nasdaq GlobeNewswire
06/09/2024
Report of transactions of shares and related securities of Bavarian Nordic by…
COPENHAGEN, Denmark, September 6, 2024– Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company's shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.The transactions concern the sale of shares following a recent exercise of warrants granted to members of the executive management as part of incentive programs launched in 2019 and 2020. The net gain from these...
Nasdaq GlobeNewswire
06/09/2024
Bc Babycare Marks a Stellar Debut at Germany's Kind+Jugend 2024
This year's Kind+Jugend hosted nearly 1,000 exhibitors from 46 countries, offering a stage for some of the world's most intriguing products. This year's Kind+Jugend hosted nearly 1,000 exhibitors from 46 countries, offering a stage for some of the world's most intriguing products. Bc Babycare, established by a designer with a vision for "creating products by thinking like parents", offers an array of solutions from food and clothing to daily essentials and travel gear—covering…
PR Newswire
06/09/2024
Microscope Camera Market to Reach USD 278 Million by 2029 with 7.8% CAGR |…
Browse in-depth TOC on "Microscope Camera Market" Browse in-depth TOC on "Microscope Camera Market" 259 - Tables54 - Figures235 - Pages Camera Type Segmentation The microscope camera market is divided into monochrome and color cameras. Color cameras are preferred due to their ability to produce color images more efficiently compared to monochrome cameras, which require additional hardware and multiple images to achieve color. The need for accurate molecular analysis...
PR Newswire
06/09/2024
Vieworks Unveils Digital Pathology Scanner LUCEON at ECP 2024
Among the four imaging modes, the tri-focal layer merge mode captures and fuses three individual images real-time, resulting in a single fusion image containing the best focused pixels from each image. A variation of the conventional Z-stack, the tri-focal layer merge Z-stack mode utilizes LUCEON's 3-camera structure to acquire images with a scan time 3 times faster and image size one-third of Z-stack. Among the four imaging modes, the tri-focal layer merge mode captures and fuses three...
PR Newswire
06/09/2024
Narwal Launches Innovative AI Robot Vacuum at IFA 2024: Stress-Free Cleaning For…
With industry-leading 12,000 Pa hyper suction power, the robot can handle even the toughest messes, while the Zero Tangling Floating Brush 2.0 ensures a tangle-free experience. The robot also excels at edge and corner cleaning with its advanced EdgeSwing™ technology, applying precise downward pressure and cleaning angles for complete coverage. Combined with its powerful navigation and cleaning systems, the Narwal Freo Z Ultra delivers an intelligent, hands-free cleaning experience for every…
PR Newswire
06/09/2024
TCL Introduces the FreshIN 3.0 Inverter Air Conditioner at IFA 2024: Redefining…
The air conditioning industry is currently facing three main challenges: respiratory health concerns, energy consumption and providing a healthy environment. TCL's third generation of FreshIN Inverter Air Conditioner addresses these challenges and redefines what consumers can expect from their home cooling solutions by not only regulating temperature, but also improving air quality, optimising energy use and reducing noise. The air conditioning industry is currently facing three main...
PR Newswire
06/09/2024
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma…
Houston, Texas and Tuebingen, Germany, September 06, 2024–Immatics N.V.(NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today announced that updated clinical data on its lead cell therapy candidate, ACTengine® IMA203 targeting PRAME, will be presented at the 21 stInternational Congress of the Society for Melanoma Research.Oral presentation Date / Time:...
Nasdaq GlobeNewswire
06/09/2024
SIFI TO PRESENT NEW PRODUCTS AND SCIENTIFIC DATA DURING THE 42ND CONGRESS OF THE…
Two new products will be introduced: Two new products will be introduced: A total of five podium presentation and five e-Posters will feature clinical outcomes on SIFI's solutions for cataract refractive surgery and ocular surface disease, such as EVOLUX, the presbyopia-correcting WELL FUSION system and the artificial tear Eyestil SYNFO. The schedule of scientific presentations is as follows: Presented Posters onSunday September 8th (14:15-15:45 | Room: Hall 6 & 7 - Pod 1) ...
PR Newswire
06/09/2024
EcoFlow Unveils Four New Portable Power Stations Series at IFA 2024…
These four portable power stations series, equipped with EcoFlow's latest X-Core 3.0 integrated architecture system, offer simple, flexible, and reliable power solutions for every lifestyle. With over 1,000 patents, X-Core 3.0 establishes new industry benchmarks in safety, charging speed, power, noise reduction, smart management, and more. These four portable power stations series, equipped with EcoFlow's latestX-Core 3.0integrated architecture system, offer simple, flexible, and reliable...
PR Newswire
06/09/2024
Major shareholder announcement
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.Per September 3, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,415,760 shares, corresponding to 5.00% (previously 4.99%) of the total share capital attached to shares. The combined total of share...
Nasdaq GlobeNewswire
06/09/2024
Altri Comunicati